dc.contributorUniversidade Estadual Paulista (UNESP)
dc.creatorTeixeira, Fábio Vieira
dc.creatorHossne, Rogério Saad
dc.creatorKotze, Paulo Gustavo
dc.creatorDenadai, Rafael
dc.creatorMiszputen, Sender Jankiel
dc.date2014-05-27T11:26:15Z
dc.date2016-10-25T18:35:56Z
dc.date2014-05-27T11:26:15Z
dc.date2016-10-25T18:35:56Z
dc.date2011-12-01
dc.date.accessioned2017-04-06T01:54:55Z
dc.date.available2017-04-06T01:54:55Z
dc.identifierJournal of Coloproctology, v. 31, n. 4, p. 325-329, 2011.
dc.identifier2237-9363
dc.identifierhttp://hdl.handle.net/11449/72890
dc.identifierhttp://acervodigital.unesp.br/handle/11449/72890
dc.identifier10.1590/S2237-93632011000400002
dc.identifierS2237-93632011000400002
dc.identifier2-s2.0-84874787555.pdf
dc.identifier2-s2.0-84874787555
dc.identifierhttp://dx.doi.org/10.1590/S2237-93632011000400002
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/893723
dc.descriptionUlcerative colitis treatment intends to induce remission, and its maintenance. Biological drugs, such as infliximab, have been indicated in moderate and severe cases of the disease, which are unresponsive to conventional medication. Randomized controlled trials proved the efficacy of biological treatment with high rates of sustained disease remission and mucosal healing. Recently, the concept of mucosal healing has been inversely associated with surgical treatment. Patients treated with infliximab have lower colectomy rates than those receiving conventional therapies. We suppose that earlier use of biological drugs in disease's course would lead to better clinical control and mucosal healing, with a consequent reduction in colectomy rates. To support this hypothesis, a literature review from January, 1996 to April, 2011 was performed.
dc.languageeng
dc.relationJournal of Coloproctology
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectBiological therapy
dc.subjectColectomy
dc.subjectColitis
dc.subjectTreatment outcome
dc.subjectUlcerative
dc.titleBiological therapy in the treatment of moderate-to-severe ulcerative colitis patients: Can colectomy be prevented?
dc.typeOtro


Este ítem pertenece a la siguiente institución